Estrogen receptor α-mediated adiposity-lowering and hypocholesterolemic actions of the selective estrogen receptor modulator acolbifene

International Journal of Obesity

Volumn 29, Issue 10, 2005, Pages 1236-1244

  Lemieux, C ^a   Phaneuf, D ^b   Labrie, F ^b   Giguere V ^c   Richard, D ^a   Deshaies, Y ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Adiposity; Blood cholesterol; EM 652; Estrogen antagonist; Estrogen receptor

Indexed keywords

ACOLBIFENE; ESTROGEN RECEPTOR ALPHA; LIPID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG RECEPTOR BINDING; ENERGY BALANCE; ESTROGEN ACTIVITY; FEMALE; HYPOCHOLESTEROLEMIA; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID LIVER LEVEL; LIPID METABOLISM; MALE; METABOLIC ACTIVATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SPECIES COMPARISON; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WHITE ADIPOSE TISSUE; WILD TYPE;

ADIPOSITY; ANIMALS; CHOLESTEROL; ESTROGEN RECEPTOR ALPHA; FEMALE; LIVER; MALE; MICE; MICE, INBRED C57BL; PIPERIDINES; RANDOM ALLOCATION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TRIGLYCERIDES;

ANIMALIA;

EID: 30544438256     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803014     Document Type: Article

References (47)

1. Baker L, Meldrum KK, Wang M, Sankula R, Vanam R, Raiesdana A, Tsai B, Hile K, Brown JW, Meldrum DR. The role of estrogen in cardiovascular disease. J Surg Res 2003; 115: 325-344.
2. McClung MR. The menopause and HRT. Prevention and management of osteoporosis. Best Pract Res Clin Endocrinol Metab 2003; 17: 53-71.
3. Rosengren A, Wedel H, Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J 1999; 20: 269-277.
4. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 1995; 273: 461-465.
5. Gohlke-Barwolf C. Coronary artery disease: is menopause a risk factor? Basic Res Cardiol 2000; 95 (Suppl 1): 177-183.
6. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000; 97: 12729-12734.
7. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 2000; 97: 12735-12740.
8. Naaz A, Zakroczymski M, Heine P, Taylor J, Saunders P, Lubahn D, Cooke PS. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res 2002; 34: 758-763.
9. Liang YQ, Akishita M, Kim S, Ako J, Hashimoto M, Iijima K, Ohike Y, Watanabe T, Sudoh N, Toba K, Yoshizumi M, Ouchi Y. Estrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord 2002; 26: 1103-1109.
10. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001; 75: 898-915.
11. McPherson R. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study. Can J Cardiol 2000; 16 (Suppl A): 14A-19A.
12. Jacobs HS. Postmenopausal hormone replacement therapy and breast cancer. Medscape Womens Health 2000; 5: E2.
13. Diamanti-Kandarakis E. Hormone replacement therapy and risk of malignancy. Curr Opin Obstet Gynecol 2004; 16: 73-78.
14. Labrie F, Labrie C, Bélanger A, Simard J, Gauthier S, Luu-The V, Mérand Y, Giguère V, Candas B, Luo S, Martel C, Singh SM, Fournier M, Coquet A, Richard V, Charbonneau R, Charpenet G, Tremblay A, Tremblay G, Cusan L, Veilleux R. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium. J Steroid Biochem Mol Biol 1999; 69: 51-84.
15. Picard F, Deshaies Y, Lalonde J, Samson P, Labrie C, Bélanger A, Labrie F, Richard D. Effects of the estrogen antagonist EM-652. HCl on energy balance and lipid metabolism in ovariectomized rats. Int J Obes Relat Metab Disord 2000; 24: 830-840.
16. Lemieux C, Picard F, Labrie F, Richard D, Deshaies Y. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet-and ovariectomy-induced obesity. Obes Res 2003; 11: 477-490.
17. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993; 90: 11162-11166.
18. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors a (ERa) and b (ERb) on mouse reproductive phenotypes. Development 2000; 127: 4277-4291.
19. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
20. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly M, Rudling M, Lindberg MK, Warner M, Angelin B, Gustafsson JA. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 2000; 278: 640-645.
21. Lindberg MK, Weihua Z, Andersson N, Moverare S, Gao H, Vidal O, Erlandsson M, Windahl S, Andersson G, Lubahn DB, Carlsten H, Dahlman-Wright K, Gustafsson JA, Ohlsson C. Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. J Endocrinol 2002; 174: 167-178.
22. Geary N. Estradiol, CCK and satiation. Peptides 2001; 22: 1251-1263.
23. Roy EJ, Wade GN. Role of food intake in estradiol-induced body weight changes in female rats. Horm Behav 1977; 8: 265-274.
24. Geary N, Asarian L, Korach KS, Pfaff DW, Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology 2001; 142: 4751-4757.
25. Brown NM, Setchell KD. Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest 2001; 81: 735-747.
26. Hewitt KN, Boon WC, Murata Y, Jones ME, Simpson ER. The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis. Endocrinology 2003; 144: 3895-3903.
27. Beynen AC, Meijer GW, Van der Meer R. Comparison of rats with mice concerning the response of lipid metabolism to dietary fats. Z Ernahrungswiss 1988; 27: 143-149.
28. McGill Jr HC, Kushwaha RS. Individuality of lipemic responses to diet. Can J Cardiol 1995; 11 (Suppl G): 15G-27G.
29. Reckless J, Metcalfe JC, Grainger DJ. Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice. Circulation 1997; 95: 1542-1548.
30. Sbarouni E, Flevari P, Kroupis C, Kyriakides ZS, Koniavitou K, Kremastinos DT. The effects of raloxifene and simvastatin on plasma lipids and endothelium. Cardiovasc Drugs Ther 2003; 17: 319-323.
31. Clarkson TB, Anthony MS, Wagner JD. A comparison of tibolone and conjugated equine estrogens effects on coronary artery atherosclerosis and bone density of postmenopausal monkeys. J Clin Endocrinol Metab 2001; 86: 5396-5404.
32. Shibata J, Toko T, Saito H, Lykkesfeldt AE, Fujioka A, Sato K, Hashimoto A, Wierzba K, Yamada Y. Estrogen agonistic/antagonistic effects of miproxifene phosphate (TAT-59). Cancer Chemother Pharmacol 2000; 45: 133-141.
33. Di Croce L, Bruscalupi G, Trentalance A. Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment. Biochem Biophys Res Commun 1996; 224: 345-350.
34. Parini P, Angelin B, Stavreus-Evers A, Freyschuss B, Eriksson H, Rudling M. Biphasic effects of the natural estrogen 17b-estradiol on hepatic cholesterol metabolism in intact female rats. Arterioscler Thromb Vasc Biol 2000; 20: 1817-1823.
35. Kovanen PT, Brown MS, Goldstein JL. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chern 1979; 254: 11367-11373.
36. Windler EE, Kovanen PT, Chao YS, Brown MS, Havel RJ, Goldstein JL. The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. J Biol Chem 1980; 255: 10464-10471.
37. Lai K, Harnish DC, Evans MJ. Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner. J Biol Chem 2003; 278: 36418-36429.
38. Xu G, Pan LX, Li H, Shang Q, Honda A, Shefer S, Bollineni J, Matsuzaki Y, Tint GS, Salen G. Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated. Am J Physiol Gastrointest Liver Physiol 2004; 286: G730-G735.
39. Bravo E, Cantafora A, Cicchini C, Avella M, Botham KM. The influence of estrogen on hepatic cholesterol metabolism and biliary lipid secretion in rats fed fish oil. Biochim Biophys Acta 1999; 1437: 367-377.
40. Dean M, Rzhetsky A, Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 2001; 11: 1156-1166.
41. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002; 110: 671-680.
42. Srivastava RA. Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen. Mol Cell Biochem 2002; 240: 67-73.
43. Tran DQ, Jin L, Chen J, McLachlan JA, Arnold SF. Evaluation of clinical and environmental anti-estrogens with human estrogen receptor expressed in Saccharomyces cerevisiae: a novel role for ABC-cassette transporters in mediating anti-estrogenic activity. Biochem Biophys Res Commun 1997; 235: 669-674.
44. Kamisako T, Ogawa H. Regulation of biliary cholesterol secretion is associated with abcg5 and abcg8 expressions in the rats: effects of diosgenin and ethinyl estradiol. Hepatol Res 2003; 26: 348-352.
45. MacGregor JI, Jordan VC. Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 1998; 50: 151-196.
46. Johnston Jr CC, Bjarnason NH, Cohen FJ, Shah A, Lindsay R, Mitlak BH, Huster W, Draper MW, Harper KD, Heath 3rd H, Gennari C, Christiansen C, Arnaud CD, Delmas PD. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med 2000; 160: 3444-3450.
47. Lindberg MK, Alatalo SL, Halleen JM, Mohan S, Gustafsson JA, Ohlsson C. Estrogen receptor specificity in the regulation of the skeleton in female mice. J Endocrinol 2001; 171: 229-236.